Targeting inflammaging in Alzheimer’s disease: molecular pathways and emerging pharmacotherapies
- DOI
- 10.1007/s10787-026-02281-8
- Published
- 2026-06-08
- Container
- Inflammopharmacology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s10787-026-02281-8,
title = {Targeting inflammaging in Alzheimer’s disease: molecular pathways and emerging pharmacotherapies},
author = {Modhi O. Alotaibi and Hayder M. Al-kuraishy and Esraa Hammadi Fahad and Ahmed M. Abdelaziz and Gaber El-Saber Batiha},
year = {2026},
journal = {Inflammopharmacology},
doi = {10.1007/s10787-026-02281-8},
url = {https://doi.org/10.1007/s10787-026-02281-8}
}RIS
TY - JOUR TI - Targeting inflammaging in Alzheimer’s disease: molecular pathways and emerging pharmacotherapies AU - Modhi O. Alotaibi AU - Hayder M. Al-kuraishy AU - Esraa Hammadi Fahad AU - Ahmed M. Abdelaziz AU - Gaber El-Saber Batiha PY - 2026 JO - Inflammopharmacology DO - 10.1007/s10787-026-02281-8 UR - https://doi.org/10.1007/s10787-026-02281-8 ER -
APA
Alotaibi, M. O., Al-kuraishy, H. M., Fahad, E. H., Abdelaziz, A. M., & Batiha, G. E. (2026). Targeting inflammaging in Alzheimer’s disease: molecular pathways and emerging pharmacotherapies. Inflammopharmacology. https://doi.org/10.1007/s10787-026-02281-8
Source records
- crossref · retrieved 2026-09-26T21:20:51.075Z